You are here

LogicBio Therapeutics

AstraZeneca pays 666% premium to buy genomic medicine biotech

Fierce Biotech

Mon, 10/3/22 - 10:26 am

LogicBio Therapeutics

genomic medicine

Intellia, LogicBio fuel hope for in vivo gene editing with new animal data in rare diseases: report

Fierce Biotech

Mon, 10/25/21 - 11:53 pm

Intellia Therapeutics

LogicBio Therapeutics

ATTR amyloidosis

FDA Clinical Hold Stops LogicBio’s Gene Editing Study Before It Starts

Xconomy

Mon, 02/10/20 - 11:25 pm

LogicBio Therapeutics

clinical trials

methylmalonic acidemia